Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Left Lateral Orbital Injection Of Botox Cosmetic Or Dysport

Research Leaders

11 sponsors active, led by JensonR+ Limited

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

5Total
Phase 1 (2)
Phase 4 (3)

Trial Status

Completed5

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT02906566Phase 4CompletedPrimary

Retinol on Human Skin Aging in East Asian Descent

NCT02391935Phase 1CompletedPrimary

Study of Intradermal Injections of RCS-01 in Male and Female Subjects

NCT01529788Phase 4CompletedPrimary

Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study

NCT01466413Phase 1CompletedPrimary

Two Formulations of ELAPR Compared to Restylane® Vital Light Following Repeat Implants in the Upper Arm Dermis

NCT01212809Phase 4CompletedPrimary

Comparative Study of Reconstituted JUVÉDERM® Ultra vs COSMODERM® 1 for Lip and Cheek Lines, Folds or Wrinkles

Showing all 5 trials

Research Network

Common Treatments

  • Left Lateral Orbital Injection Of Botox Cosmetic Or Dysport1
  • Juvéderm Ultra1
  • Retinol1
  • Tropoelastin1
  • Cosmoderm 11

Active Sponsors

  • JensonR+ Limited1
  • Elastagen Pty Ltd1
  • Medicis Pharmaceutical Corporation1
  • RepliCel Life Sciences, Inc.1
  • Stanford University1

Top Investigators

Related Conditions

  • Skin Wrinkling1
  • Solar Degeneration Of Skin1
  • Solar Elastosis1

Activity Timeline